| Literature DB >> 36177353 |
Thomas Fink1, Thomas Eitz2, Christian Sohns1, Philipp Sommer1, Guram Imnadze1.
Abstract
Background: Cardiac resynchronization therapy (CRT) by implantation of an endocardial coronary sinus (CS) pacing lead is an established heart failure therapy. The recent European Society of Cardiology (ESC) guidelines on cardiac pacing and CRT recommend conduction system pacing (CSP) as a potential bail-out therapy in patients with previously unsuccessful CS-lead implantation. We present a case in which unsuccessful implantation of a CS pacing and ineffective QRS correction by His-bundle pacing (HBP) was overcome by left-bundle branch pacing (LBBP) to achieve cardiac resynchronization. Case summary: The patient had to undergo revision of a CS lead for CRT due to rising pacing thresholds and pacing impedance. CS-lead implantation was omitted by a stenotic posterolateral CS branch. HBP did not lead to adequate QRS correction. The patient underwent successful LBB lead implantation as bail-out therapy. After LBBP lead implantation electrocardiographic and echocardiographic parameters were evident of effective CRT. Discussion: Conduction system pacing may be an alternative to CS pacing for CRT in heart failure patients, which is endorsed by the current European guidelines. LBBP may overcome limitations of HBP and provide an alternative to other strategies such as surgical implantation of epicardial left-ventricular pacing leads. Further studies are needed to fully clarify the role of LBBP for heart failure treatment.Entities:
Keywords: Case report; Conduction system pacing; Failed cardiac resynchronization therapy; Heart failure; Left-bundle branch pacing
Year: 2022 PMID: 36177353 PMCID: PMC9514101 DOI: 10.1093/ehjcr/ytac375
Source DB: PubMed Journal: Eur Heart J Case Rep ISSN: 2514-2119
| 2005 |
| Implantable cardioverter defibrillator (ICD) implantation for primary prevention |
| 2013 |
| ICD generator change |
| 2019 |
| Upgrade to CRT-D system due to clinical heart failure and new complete LBBB |
| EF increased from 24 to 33%, clinical improvement (NYHA III to NYHA I–II) |
| 2020 |
| |
| |
| Failed revision of LV lead due to CS branch occlusion, new RV lead implantation |
| 2020 |
| Current attempt to undergo LBBP |